Z-2370-2020 Class II Terminated
FDA device recall Z-2370-2020 was initiated by Abbott Vascular on Mar 25, 2020 and is designated Class II. Reason for recall: Incorrect expiration date The recall status is terminated (terminated Jul 12, 2021). Affected quantity: 13 units.
Recall details
- Product Type
- Devices
- Report Date
- Jun 24, 2020
- Initiation Date
- Mar 25, 2020
- Termination Date
- Jul 12, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13 units
Product description
Xience Sierra TM Everolimus Eluting Coronary Stent System, RX 3.5mm x 33mmStrength: 100 ¿g/cm¿, Nominal Everolimus Content: 209 ¿g; Lot number 903224A,
Reason for recall
Incorrect expiration date
Distribution pattern
US Nationwide distribution including in the states of NJ, HI, MD, FL, NV, CA, KS and PR. No foreign consignee
Code information
Lot Number: 903224A; Device Identifier/GTIN 08717648227455
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2370-2020
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Abbott Vascular? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.